MedPath

Image-Guided Tumorboost of Bladder Cancer

Phase 1
Completed
Conditions
Bladder Neoplasms
Interventions
Radiation: Radiation boost
Registration Number
NCT00963404
Lead Sponsor
University of Aarhus
Brief Summary

The purpose of the study is to increase the radiation dose (Boost) to the bladder tumor. The bladder cancer patients included in the study will undergo tumor demarcation. The bladder demarcations will then be the target for an image-guided boost delivered precisely to the expected tumor site.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Muscle invasive bladder cancer (transitional carcinoma)
  • Unifocal
  • TNM stage T2a-4a, N0-1, M0
  • unfit for radical cystectomy
Exclusion Criteria
  • Hyperthyroidism
  • Multinodular goiter
  • Pregnancy
  • Breast feeding
  • WHO preformance status more than 2
  • Iodine allergy
  • MRI or CT contrast media allergy
  • Bi-lateral hip-prosthesis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Tumor-boostRadiation boostImage-guided tumorboost of the bladder cancer.
Primary Outcome Measures
NameTimeMethod
Local tumor controlOne year
Secondary Outcome Measures
NameTimeMethod
Acute and late adverse effects of the radiotherapy treatment3 years

Trial Locations

Locations (4)

The department of Oncology, Aarhus University Hospital

🇩🇰

Aarhus, Denmark

The department of Oncology, Rigshospitalet

🇩🇰

Copenhagen, Denmark

The department of Oncology, Herlev University Hospital

🇩🇰

Herlev, Denmark

The department of Oncology, Odense University Hospital

🇩🇰

Odense, Denmark

© Copyright 2025. All Rights Reserved by MedPath